G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer

OncoImmunology

Volumn 5, Issue 3, 2016, Pages

  Hollmén, Maija ^a   Karaman, Sinem ^a   Schwager, Simon ^a   Lisibach, Angela ^a   Christiansen, Ailsa J ^a   Maksimow, Mikael ^b   Varga, Zsuzsanna ^c   Jalkanen, Sirpa ^b   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CSF3; HLA DR; M CSF; TGF ; TNBC; tumor associated macrophages

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; ESTROGEN RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; PLATELET DERIVED GROWTH FACTOR BB; PROLYLLEUCYLGLYCINAMIDE; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CANCER PROGNOSIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL VIABILITY ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OVERALL SURVIVAL; SURVIVAL RATE; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING;

EID: 84961671990     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1115177     Document Type: Article

References (52)

1. P.Boyle. The globalisation of cancer. Lancet 2006; 368:629-30; PMID:16920452; http://dx.doi.org/10.1016/S0140-6736(06)69225-8
2. P.Boyle. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 2012; 23 Suppl 6:vi7-12; PMID:23012306; http://dx.doi.org/10.1093/annonc/mds187
3. J.Crown, J.O'Shaughnessy, G.Gullo. Emerging targeted therapies in triple-negative breast cancer. Ann Oncol 2012; 23 Suppl 6:vi56-65; PMID:23012305; http://dx.doi.org/10.1093/annonc/mds196
4. A.Mantovani, P.Allavena, A.Sica, F.Balkwill. Cancer-related inflammation. Nature 2008; 454:436-44; PMID:18650914; http://dx.doi.org/10.1038/nature07205
5. R.D.Leek, C.E.Lewis, R.Whitehouse, M.Greenall, J.Clarke, A.L.Harris. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56:4625-9; PMID:8840975
6. S.M.Mahmoud, A.H.Lee, E.C.Paish, R.D.Macmillan, I.O.Ellis, A.R.Green. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol 2012; 65:159-63; PMID:22049225; http://dx.doi.org/10.1136/jclinpath-2011-200355
7. A.Mantovani, A.Sica. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22:231-7; PMID:20144856; http://dx.doi.org/10.1016/j.coi.2010.01.009
8. A.Mantovani, S.Sozzani, M.Locati, P.Allavena, A.Sica. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5
9. M.Stein, S.Keshav, N.Harris, S.Gordon. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287-92; PMID:1613462; http://dx.doi.org/10.1084/jem.176.1.287
10. F.Pucci, M.A.Venneri, D.Biziato, A.Nonis, D.Moi, A.Sica, C.Di Serio, L.Naldini, M.De Palma. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009; 114:901-14; PMID:19383967; http://dx.doi.org/10.1182/blood-2009-01-200931
11. A.Sica, A.Saccani, B.Bottazzi, N.Polentarutti, A.Vecchi, J.van Damme, A.Mantovani. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J Immunol 2000; 164:762-7; PMID:10623821; http://dx.doi.org/10.4049/jimmunol.164.2.762
12. C.Stockmann, A.Doedens, A.Weidemann, N.Zhang, N.Takeda, J.I.Greenberg, D.A.Cheresh, R.S.Johnson. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 2008; 456:814-8; PMID:18997773; http://dx.doi.org/10.1038/nature07445
13. E.Y.Lin, A.V.Nguyen, R.G.Russell, J.W.Pollard. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193:727-40; PMID:11257139; http://dx.doi.org/10.1084/jem.193.6.727
14. S.Aharinejad, P.Paulus, M.Sioud, M.Hofmann, K.Zins, R.Schäfer, E.R.Stanley, D.Abraham. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 2004; 64:5378-84; PMID:15289345; http://dx.doi.org/10.1158/0008-5472.CAN-04-0961
15. P.Paulus, E.R.Stanley, R.Schäfer, D.Abraham, S.Aharinejad. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res 2006; 66:4349-56; PMID:16618760; http://dx.doi.org/10.1158/0008-5472.CAN-05-3523
16. M.Ryder, M.Gild, T.M.Hohl, E.Pamer, J.Knauf, R.Ghossein, J.A.Joyce, J.A.Fagin. Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One 2013; 8:e54302; PMID:23372702; http://dx.doi.org/10.1371/journal.pone.0054302
17. S.M.Pyonteck, L.Akkari, A.J.Schuhmacher, R.L.Bowman, L.Sevenich, D.F.Quail, O.C.Olson, M.L.Quick, J.T.Huse, V.Teijeiro et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19:1264-72; PMID:24056773; http://dx.doi.org/10.1038/nm.3337
18. C.H.Ries, M.A.Cannarile, S.Hoves, J.Benz, K.Wartha, V.Runza, F.Rey-Giraud, L.P.Pradel, F.Feuerhake, I.Klaman et al. Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy. Cancer Cell, 2014; 25(6):846-59; PMID: 24898549; http://dx.doi.org/10.1016/j.ccr.2014.05.016
19. I.Görgen, T.Hartung, M.Leist, M.Niehörster, G.Tiegs, S.Uhlig, F.Weitzel, A.Wendel. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 1992; 149:918-24; PMID:1378868
20. A.R.Fraser, G.Cook, I.M.Franklin, J.G.Templeton, M.Campbell, T.L.Holyoake, J.D.Campbell. Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. J Leukoc Biol 2006; 80:862-9; PMID:16895973; http://dx.doi.org/10.1189/jlb.0605297
21. E.M.Boneberg, L.Hareng, F.Gantner, A.Wendel, T.Hartung. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 2000; 95:270-6; PMID:10607712
22. P.Klangsinsirikul, N.H.Russell. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002; 30:495-501; PMID:12031657; http://dx.doi.org/10.1016/S0301-472X(02)00785-3
23. M.Hollmén, F.Roudnicky, S.Karaman, M.Detmar. Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep 2015; 5:9188; PMID:25776849; http://dx.doi.org/10.1038/srep09188
24. O.Giricz, V.Calvo, E.A.Peterson, C.M.Abouzeid, P.A.Kenny. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion. Int J Cancer 2013; 133:2587-95; PMID:23729230
25. N.R.West, J.I.Murray, P.H.Watson. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. Oncogene 2014; 33:1485-94; PMID:23584474; http://dx.doi.org/10.1038/onc.2013.105
26. B.D.Lehmann, J.A.Bauer, X.Chen, M.E.Sanders, A.B.Chakravarthy, Y.Shyr, J.A.Pietenpol. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121:2750-67; PMID:21633166; http://dx.doi.org/10.1172/JCI45014
27. V.T.Phan, X.Wu, J.H.Cheng, R.X.Sheng, A.S.Chung, G.Zhuang, C.Tran, Q.Song, M.Kowanetz, A.Sambrone et al. Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment. Proc Natl Acad Sci U S A 2013; 110:6079-84; PMID:23530240; http://dx.doi.org/10.1073/pnas.1303302110
28. C.Medrek, F.Pontén, K.Jirström, K.Leandersson. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012; 12:306; PMID:22824040; http://dx.doi.org/10.1186/1471-2407-12-306
29. C.J.Aslakson, F.R.Miller. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52:1399-405; PMID:1540948
30. J.D.Waight, Q.Hu, A.Miller, S.Liu, S.I.Abrams. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 2011; 6:e27690; PMID:22110722; http://dx.doi.org/10.1371/journal.pone.0027690
31. T.Mitsui, S.Watanabe, Y.Taniguchi, S.Hanada, Y.Ebihara, T.Sato, T.Heike, M.Mitsuyama, T.Nakahata, K.Tsuji. Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice. Blood 2003; 101:2990-5; PMID:12672695; http://dx.doi.org/10.1182/blood.V101.8.2990
32. M.Kowanetz, X.Wu, J.Lee, M.Tan, T.Hagenbeek, X.Qu, L.Yu, J.Ross, N.Korsisaari, T.Cao et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A 2010; 107:21248-55; PMID:21081700; http://dx.doi.org/10.1073/pnas.1015855107
33. F.Shojaei, X.Wu, X.Qu, M.Kowanetz, L.Yu, M.Tan, Y.G.Meng, N.Ferrara. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc Natl Acad Sci U S A 2009; 106:6742-7; PMID:19346489; http://dx.doi.org/10.1073/pnas.0902280106
34. A.Swierczak, A.D.Cook, J.C.Lenzo, C.M.Restall, J.P.Doherty, R.L.Anderson, J.A.Hamilton. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor. Cancer Immunol Res 2014; 2:765-76; PMID:25005824; http://dx.doi.org/10.1158/2326-6066.CIR-13-0190
35. S.Rutella, F.Zavala, S.Danese, H.Kared, G.Leone. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 2005; 175:7085-91; PMID:16301609; http://dx.doi.org/10.4049/jimmunol.175.11.7085
36. U.Bharadwaj, M.Li, R.Zhang, C.Chen, Q.Yao. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 2007; 67:5479-88; PMID:17545630; http://dx.doi.org/10.1158/0008-5472.CAN-06-3963
37. M.Toyoda, K.Chikamatsu, K.Sakakura, Y.Fukuda, K.Takahashi, M.Miyashita, K.Shimamura, N.Furuya. A case of squamous cell carcinoma of the head and neck producing granulocyte-colony stimulating factor with marked leukocytosis. Auris Nasus Larynx 2007; 34:267-71; PMID:17097253; http://dx.doi.org/10.1016/j.anl.2006.07.014
38. N.Ito, T.Matsuda, Y.Kakehi, E.Takeuchi, T.Takahashi, O.Yoshida. Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 1990; 323:1709-10; PMID:1700300
39. T.Obara, Y.Ito, T.Kodama, Y.Fujimoto, H.Mizoguchi, K.Oshimi, M.Takahashi, A.Hirayama. A case of gastric carcinoma associated with excessive granulocytosis. Production of a colony-stimulating factor by the tumor. Cancer 1985; 56:782-8; PMID:3874682; http://dx.doi.org/10.1002/1097-0142(19850815)56:4%3c782::AID-CNCR2820560414%3e3.0.CO;2-5
40. K.T.Morris, H.Khan, A.Ahmad, L.L.Weston, R.A.Nofchissey, I.V.Pinchuk, E.J.Beswick. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer 2014; 110:1211-20; PMID:24448357; http://dx.doi.org/10.1038/bjc.2013.822
41. S.Nagata, M.Tsuchiya, S.Asano, O.Yamamoto, Y.Hirata, N.Kubota, M.Oheda, H.Nomura, T.Yamazaki. The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor. EMBO J 1986; 5:575-81; PMID:2423327
42. J.Stein, G.V.Borzillo, C.W.Rettenmier. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood 1990; 76:1308-14; PMID:2145044
43. O.Gluz, C.Liedtke, N.Gottschalk, L.Pusztai, U.Nitz, N.Harbeck. Triple-negative breast cancer–current status and future directions. Ann Oncol 2009; 20:1913-27; PMID:19901010; http://dx.doi.org/10.1093/annonc/mdp492
44. M.F.Rimawi, P.B.Shetty, H.L.Weiss, R.Schiff, C.K.Osborne, G.C.Chamness, R.M.Elledge. Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer 2010; 116:1234-42; PMID:20082448; http://dx.doi.org/10.1002/cncr.24816
45. A.S.Chung, X.Wu, G.Zhuang, H.Ngu, I.Kasman, J.Zhang, J.M.Vernes, Z.Jiang, Y.G.Meng, F.V.Peale et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 2013; 19:1114-23; PMID:23913124; http://dx.doi.org/10.1038/nm.3291
46. Z.Granot, E.Henke, E.A.Comen, T.A.King, L.Norton, R.Benezra. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011; 20:300-14; PMID:21907922; http://dx.doi.org/10.1016/j.ccr.2011.08.012
47. K.Asano, A.Nabeyama, Y.Miyake, C.H.Qiu, A.Kurita, M.Tomura, O.Kanagawa, S.Fujii, M.Tanaka. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011; 34:85-95; PMID:21194983; http://dx.doi.org/10.1016/j.immuni.2010.12.011
48. K.Ohnishi, Y.Komohara, Y.Saito, Y.Miyamoto, M.Watanabe, H.Baba, M.Takeya. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci 2013; 104:1237-44; PMID:23734742; http://dx.doi.org/10.1111/cas.12212
49. Y.Saito, K.Ohnishi, A.Miyashita, S.Nakahara, Y.Fujiwara, H.Horlad, T.Motoshima, S.Fukushima, M.Jinnin, H.Ihn et al. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res 2015; Dec; 3(12):1356-63; PMID:26297710
50. R.M.Neve, K.Chin, J.Fridlyand, J.Yeh, F.L.Baehner, T.Fevr, L.Clark, N.Bayani, J.P.Coppe, F.Tong et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10:515-27; PMID:17157791; http://dx.doi.org/10.1016/j.ccr.2006.10.008
51. J.P.Theurillat, F.Ingold, C.Frei, A.Zippelius, Z.Varga, B.Seifert, Y.T.Chen, D.Jäger, A.Knuth, H.Moch. NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. Int J Cancer 2007; 120:2411-7; PMID:17294444; http://dx.doi.org/10.1002/ijc.22376
52. K.Movahedi, D.Laoui, C.Gysemans, M.Baeten, G.Stangé, J.Van den Bossche, M.Mack, D.Pipeleers, P.In't Veld, P.De Baetselier et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010; 70:5728-39; PMID:20570887; http://dx.doi.org/10.1158/0008-5472.CAN-09-4672